Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1981-6-13
pubmed:abstractText
Intraperitoneal injection of maximally effective doses of corticotropin(1-24) [ACTH(1-24)] provoked maximal increases in rat adrenal phospholipids as follows: phosphatidic acid within 1.5-2 min, phosphatidylinositol and phosphatidylglycerol within 4-6 min, and polyphosphoinositides and corticosterone within 5-15 min. Continued maximal adrenal stimulation by ACTH(1-18) treatment caused sustained increases in adrenal phosphatidic acid, phosphatidylinositol, phosphatidylglycerol, polyphosphoinositides, and corticosterone. Treatment with cycloheximide during this steady-state caused rapid decreases in all of these substances to basal levels. The observed half-lives of adrenal phosphatide acid, phosphatidylinositol, polyphosphoinositides, phosphatidylglycerol, and corticosterone during cycloheximide inhibition were 0.15, 1.0, 1.7, 3.3, and 3.5 min, respectively. Calculated production rates during maximal ACTH stimulation were 1060, 991, 90, 34, and 41 nmol/g of tissue per min, respectively. These findings suggest that (i) an initial effect of ACTH on de novo synthesis of phosphatidic acid can account for all subsequently observed increases in other phospholipid derivatives of CDP-diacylglycerol, (ii) a labile protein is required for the ACTH-induced increase in phosphatidic acid, (iii) the phosphatidate leads to polyphosphoinositide-polyglycerophospholipid pathway is rapidly and dramatically responsive to hormonal stimulation, (iv) changes in steroidogenesis correlate well with changes in this phospholipid pathway, and (v) stimulation of this pathway is rapidly reversible.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-1094912, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-12325369, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-13189589, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-13561538, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-13587500, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-164246, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-175238, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-180679, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-205250, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-220223, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-222747, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-228742, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-4285998, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-4290300, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-4293733, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-4334277, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-4339524, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-4344642, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-4375423, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-4583220, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-6247344, http://linkedlifedata.com/resource/pubmed/commentcorrection/6261246-6251113
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7189-93
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Kinetic aspects of cycloheximide-induced reversal of adrenocorticotropin effects on steroidogenesis and adrenal phospholipids in vivo.
pubmed:publicationType
Journal Article